Actively Recruiting

Phase Not Applicable
Age: 10Weeks +
All Genders
NCT07137234

Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.

Led by Mansoura University · Updated on 2026-02-10

32

Participants Needed

1

Research Sites

58 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.

CONDITIONS

Official Title

Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.

Who Can Participate

Age: 10Weeks +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with mild to severe unilateral cleft lip requiring repair
  • Free from any systemic disease
  • With or without cleft palate
  • Fit for general anesthesia
Not Eligible

You will not qualify if you...

  • Patients with syndromic type of cleft lip
  • Patients with systemic disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mansoura University

Al Mansurah, Egypt

Actively Recruiting

Loading map...

Research Team

B

Basel Saeed Shamaa, Master's

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here